Improving the Quality of Care While Reducing Costs

Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.

Processing over 4 billion heartbeats a day

Monitoring over 1 Million patients per year

Each month more than 30,000 physicians refer patients to our products

Provided over 1 million reports to physicians with information for diagnosis and therapy management

Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued

Over $300 million invested in the technology and service platform

BioTel Heart is the leading provider of remote cardiac monitoring diagnostic services.

See Why

Need help with your heart monitor?

Find product details, quick start guides and more at


BioTel Research is an industry leader in clinical trials testing services, monitoring, data, and scientific consulting.

Learn More

Latest News

BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results

Company Delivers Record Revenue and Adjusted EBITDA Exceeds Expectations

February 22, 2018

BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018

BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2017 earnings on Thursday, February 22nd at 4:00 PM Eastern Time.

February 12, 2018

BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.

November 30, 2017